Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioXcel Therapeutics (BTAI) Interest Coverage Ratio (2022 - 2025)

BioXcel Therapeutics has reported Interest Coverage Ratio over the past 4 years, most recently at 2.62 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 2.62 for Q4 2025, down 6.72% from a year ago — trailing twelve months through Dec 2025 was 3.2 (up 26.85% YoY), and the annual figure for FY2025 was 3.29, up 25.95%.
  • Interest Coverage Ratio for Q4 2025 was 2.62 at BioXcel Therapeutics, up from 3.25 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for BTAI hit a ceiling of 2.45 in Q4 2024 and a floor of 4497.14 in Q1 2022.
  • Median Interest Coverage Ratio over the past 4 years was 8.17 (2023), compared with a mean of 290.27.
  • Peak annual rise in Interest Coverage Ratio hit 99.62% in 2023, while the deepest fall reached 40.93% in 2023.
  • BioXcel Therapeutics' Interest Coverage Ratio stood at 25.68 in 2022, then skyrocketed by 62.46% to 9.64 in 2023, then surged by 74.55% to 2.45 in 2024, then decreased by 6.72% to 2.62 in 2025.
  • The last three reported values for Interest Coverage Ratio were 2.62 (Q4 2025), 3.25 (Q3 2025), and 4.14 (Q2 2025) per Business Quant data.